Physician profile
Nathan Daniel Smith
NPI 1437413531
$1,392.10
in general payments reported to CMS, 2019-2025
15 companies · $709 in 2025
The $709 reported for 2025 was more than what 94% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $34.73 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $467 · Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $466.80 |
| Food and Beverage | $242.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $670.94 | 2025 | 2nd Gen Centrimag Primary Console |
| Amgen INC. | $134.60 | 2019 | |
| Sunovion Pharmaceuticals INC. | $113.58 | 2019 | |
| Sanofi-Aventis U.S. LLC | $78.75 | 2019 | |
| Glaxosmithkline, LLC. | $55.92 | 2019-2020 | |
| Pfizer INC. | $52.79 | 2019-2020 | |
| Allergan, INC. | $47.32 | 2019 | |
| Astellas Pharma US INC | $47.24 | 2019 | |
| Novo Nordisk INC | $45.61 | 2019-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $36.49 | 2019 | |
| Mylan Specialty L.P. | $30.01 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.79 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $22.73 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.42 | 2025 | |
| Sanofi Pasteur INC. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.